GRI Bio Prices up to $13 Million Equity Offering

MT Newswires Live04-01

GRI Bio (GRI) said Tuesday that it priced a public equity offering of common shares and warrants for a combined price of $3.60 per share and accompanying warrants.

The offering includes about 1.4 million shares of common stock for gross proceeds of $5.0 million. The offering also includes series E-1 warrants, short-term series E-2 warrants, and short-term series E-3 warrants, each series to purchase up to 1.4 million shares.

The warrants have an exercise price of $3.20 per share. If all warrants are exercised in full, the total proceeds to the company are expected to be roughly $13.3 million.

Net proceeds from the offering will be used for product candidate development, working capital and general corporate purposes, GRI added.

Shares were up more than 6% in recent trading.

Price: 3.00, Change: -0.20, Percent Change: -6.25

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment